-
Posted by
Two Blokes Jul 29 -
Filed in
Stock
-
2 views
VANCOUVER, BC / ACCESS Newswire / July 29, 2025 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a biopharmaceutical company focused on developing therapeutics for rare and underserved diseases, today announced its formal engagement with ArcStone Securities and Investments Corp. ("ArcStone"), a capital markets advisory firm.
